|
|
||||||||


*
Laboratoire dImmunochimie, Commissariat à lEnergie Atomique-Grenoble, Département de Biologie Moléculaire et Structurale, Institut National de la Santé et de la Recherche Médicale U548, Université Joseph Fourier, Grenoble, France;
Unité des Cytokines et Développement Lymphoïde, Département dImmunologie, Institut Pasteur, Paris, France; and
Centre dImmunologie de Marseille-Luminy, Institut National de la Santé et de la Recherche Médicale-Centre National de la Recherche Scientifique, Marseille, France
| Abstract |
|---|
|
|
|---|
and CD3
complex molecules within a pre-TCR. Signaling from the pre-TCR via the
CD3 complex is thought to be required to promote TCRA gene
accessibility and recombination. However, 
+
thymocytes do develop in pT
-deficient mice, showing that
TCR
-chain genes are rearranged, either in
CD4-CD8- or CD4+CD8+
thymocytes, in the absence of pre-TCR expression. In this
study, we analyzed the TCRA gene recombination status of
early immature thymocytes in mutant mice with arrested thymocyte
development, deficient for either CD3 or pT
and
c expression.
ADV genes belonging to different families were found
rearranged to multiple AJ segments in both cases. Thus,
TCRA gene rearrangement is independent of CD3 and
c
signaling. However, CD3 expression was found to play a role in
transcription of rearranged TCR
-chain genes in
CD4-CD8- thymocytes. Taken together, these
results provide new insights into the molecular control of early T cell
differentiation. | Introduction |
|---|
|
|
|---|

T cell maturation (reviewed in Ref. 1). The
thymocytes first proceed through a double-negative
(DN)3
CD4-CD8- stage of
development. The regulated expression of CD44 and CD25 defines four DN
subpopulations: the early T cell precursors, which are
CD44+CD25- (DN1), become
successively CD44+CD25+
(DN2), CD44-CD25+ (DN3),
and CD44-CD25- (DN4). The
CD44-CD25- thymocytes
proliferate, then develop through CD4low or
CD8low intermediates called immature
single-positive (SP) cells, to finally enter the
CD4+CD8+ double-positive
(DP) stage. At this point, thymocytes begin to express low levels of

TCR and are selected to become mature SP
CD4+ or CD8+ according to
the specificity of their TCR. A second subset of T cells
bearing a TCR
at the surface develop in the thymus from the same
progenitor population (2). Unlike

+ T cells, 
+ T
cells differentiate along the DN stage of development and in general,
do not express the CD4 or CD8 coreceptors (reviewed in Ref.
3).
TCRB, TCRD, and TCRG rearrangements
are initiated in DN during a first wave of expression of
recombination-activating gene (RAG)-1 and RAG-2
(4 and reviewed in Ref. 5). In adult mice,
TCRB gene rearrangements are initiated at the transition
between the DN2 and DN3 stage of development, whereas TCRD
and TCRG rearrangements are initiated earlier in DN2 cells
(6, 7). At the DN/DP transition, cells encounter a
checkpoint, known as
selection, which allows only those cells
expressing in-frame TCR
chains to survive and proceed further. This
process is controlled by the pre-TCR, composed of the neosynthesized
TCR
chain associated to the invariant pT
chain and the CD3
complex (8, 9, 10, 11). Pre-TCR expression at the surface of DN3
thymocytes induces their differentiation into DP cells and a burst of
proliferation, which are impeded in the absence of a functional pre-TCR
(12, 13, 14, 15, 16, 17, 18). The pre-TCR may also play an important role in

vs 
commitment (19). It is generally
considered that TCRA gene rearrangement is initiated after
pre-TCR expression when the cells transit from DN to DP, once the
second wave of expression of RAG-1 and RAG-2 is
triggered (4, 20).
The TCRAD locus has the particularity to be composed of
TCRA and TCRD gene segments, the TCRD
genes being embedded between the TCRA genes. Between 75 and
100 ADV segments and 60 AJ segments are available
for V(D)J recombination in mice (21, 22, 23). Accessibility of
the TCR gene segments for V(D)J recombination is controlled
in part by enhancer elements located in the TCR loci
(reviewed in Refs. 24, 25, 26). A TCRA enhancer
(E
) situated just downstream of AC and a TCRD
enhancer (E
) located between DJ2 and DC have
been identified (27, 28). Studies using E
and E
as
part of transgenic artificial recombination substrates showed that
these elements promote rearrangement of reporter genes after pre-TCR
expression, in DN4 thymocytes, and in earlier DN cells, respectively
(29, 30). These enhancers are thus implicated in the
tissue- and stage-specific control of their respective substrates.
However, it was later shown that TCRA and TCRD
gene rearrangements are found in E
-/- and
E
-/- mice, respectively, indicating that
other elements are instrumental in the control of accessibility of
the TCRAD locus (31, 32, 33). To explain the
differential temporal use of the proximal TCRD and
TCRA genes in DN and DP cells, respectively, it was proposed
(in human) that blocking element 
1, situated between the
DC and AJ segments, prevents the upstream E
to
promote accessibility to the AJ genes in DN cells
(34). In this context, the block over the AJ
region would be released in late DN/early DP at the time of E
activation, after pre-TCR signaling.
In addition to these results, most of the data available to date
indicate that TCRA coding genes are not rearranged before
the DN to DP transition. Because the complex structure of the
TCRAD locus makes TCRA gene rearrangements
difficult to study at the genomic level, most of these studies relied
on Northern blot analysis (20, 35, 36), rather than direct
analysis of rearrangement events at the DNA level. TCRA
genes were found expressed only after the thymocytes did exit the DN
compartment. Furthermore, mimicking pre-TCR signaling by injection of
anti-CD3
Abs not only induces DP thymocyte differentiation, but
also increases TCRA gene germline transcription, an event
thought to reflect accessibility of these genes (37). In
addition, TCRB, TCRD, and TCRG, but
not TCRA genes were found rearranged and transcribed in
CD3
-deficient mice (15, 17, 38, 39). Collectively,
these data were interpreted as evidence that pre-TCR-derived signals
are required to induce accessibility and rearrangement of
TCRA genes. However, TCR
+
thymocytes still develop in pT
-deficient mice, in absence of
pre-TCR, and we showed that the TCR
chains expressed in
pT
-/- thymocytes display features identical
to that found in wild-type (wt) animals (40).
Pre-TCR-independent DP thymocyte differentiation can be achieved
through the influence of TCR
or TCR
chain expression
(41, 42). Nonetheless, analysis of pT
x TCR
double-deficient animals showed that DP thymocytes still develop in
these mice, and that almost all of them have been
selected
(43). This phenomenon was postulated to happen through
pre-TCR-independent early rearrangement and expression of TCR
chains, able to substitute for pT
and form a TCR
that promotes
the progression of TCR
-expressing DN thymocytes to the DP and SP
compartments. One other study found rearranged TCR
chain genes in
sorted immature DN3 wt thymocytes (44). However, it was
later shown that a pre-TCR can potentially be expressed in DN2
thymocytes (45), and that the DN3 population includes
thymocytes that have already undergone
selection (46).
Thus, TCRA rearrangements found in wt DN3 thymocytes may
result from pre-TCR signaling. Therefore, it has not yet been formally
demonstrated whether TCR
chain genes can be rearranged before
pre-TCR expression, and, if so, how they are induced.
In this study, we analyzed the occurrence of TCRA gene
rearrangement in different models of genetically modified mice, in
which thymocyte differentiation is blocked at or before the
CD44-CD25+ stage. Our
results show that TCRA gene rearrangement does take place in
immature thymocytes, independently of the main signals governing
thymocyte differentiation, namely CD3, pre-TCR, TCR, and
c
expression and signaling. Furthermore, we also show that CD3 is
required for TCRA rearrangements to be transcribed at these
early stages of development.
| Materials and Methods |
|---|
|
|
|---|
CD3
5/
5 (15) and
RAG-2-/- mice (13) were maintained
in the animal facility of the Commissariat à lEnergie Atomique
(Grenoble, France), and E
-/- x
TCR
-/- (47, 48) and
c-/- x pT
-/-
mice (45) in the animal facilities of the Center
dImmunologie de Marseille Luminy (Marseille, France) and of the
Centre National de la Recherche Scientifique/Centre de
Développement des Techniques Avancées
(Orléans, France), respectively. All mice used were
between 4 and 10 wk of age. C57BL/6 mice were used as wt control.
RNA preparation and RT-PCR
Total RNA and cDNA from E
-/- x
TCR
-/- and
CD3
5/
5 thymi were prepared as previously
described (40, 48). PCR were conducted using
oligonucleotides specific for the ADV2, ADV3, or
ADV7 family genes (CDNAU, ADV3UP, or ADV7UP, respectively)
and for the AC region (MTA). Thy-1 cDNA was
amplified with the Thy-1UP and Thy-1DO primers as a positive control.
PCR products were migrated on 1.5% agarose gels and probed by Southern
blot hybridization using 32P-labeled primers
specific for the AC region or Thy-1 (C
2 and
Thy-1UP2 primers, respectively). Primer sequences are shown in Fig. 1
A.
|
primer (C
1)
to introduce restriction sites to facilitate cloning. The conditions
for all the PCR were 5 min at 94°C, followed by 35 cycles consisting
of 30 s at 94°C, 30 s at 60°C, 1 min at 72°C, and
finally 10 min at 72°C. Cell sorting
The following Abs were used for staining: FITC-conjugated
anti-CD25 (7D4), PE-conjugated anti-CD4 (GK1.5) and
anti-CD44 (IM7), biotin-conjugated anti-B220 (RA3-6B2),
anti-CD8 (53-6.7), anti-CD3
(2C11), anti-CD11b (M1/70),
anti-I-Ab (25-9-17), and anti-TCR
(H57-597). All the Abs and PE-conjugated streptavidin were purchased
from BD PharMingen (Le Pont de Claix, France).
Single-cell suspensions of CD3
5/
5
thymocytes were prepared and incubated with the indicated Abs, as
previously described (40). CD25+
thymocytes were electronically sorted on a
FACStarPlus (BD Biosciences, San Diego, CA) using
CellQuest software. The purity of sorted cells, assessed by reanalysis,
was >99%.
Detection of TCRAD locus rearrangements
Genomic DNA was extracted and amplified using primers situated
downstream of different AJ gene segments (AJ56,
AJ48, AJ27, or AJ23) in combination
with primers specific for the ADV2, ADV7,
ADV8, or ADV10 family genes (CDNAU, ADV7UP,
V
8L, or ADV10UP, respectively). A control PCR was performed on the
AC region using NM78 and MTCADO2 primers. The sequence of
the primers and the location of AJ-specific oligonucleotides
used to amplify ADV-AJ rearrangements are shown in Fig. 1
.
Multiplex PCR were performed with the Expend High Fidelity PCR system
(Roche Diagnostics, Meylan, France), as follows: 5 min at 94°C,
followed by 26 cycles consisting of 1 min at 94°C, 1 min at 58°C, 6
min at 72°C, and finally 10 min at 72°C. With 26 cycles, the PCRs
were in the linear phase of amplification (data not shown). PCR
products were migrated on 1.6% agarose gels and probed by Southern
blot hybridization. The probes used to detect the TCRA
rearrangements were specific of the AJ gene segments (AJ56p,
AJ48p, AJ27p, AJ23p). Each of these oligonucleotides was first used
individually to probe ADV2-AJ PCR products amplified from wt thymocyte
DNA. In each case, only the expected were revealed. Thereafter, AJ56p,
AJ48p, AJ27p, and AJ23p were used as a mix to probe ADV-AJ PCR
products. The NM78/MTCADO2 PCR products were probed with the C
2
primer.
To clone TCRA rearrangements using the AJ56,
AJ48, AJ27, and AJ23 segments, DNA
from CD3
-deficient thymocytes was amplified by PCR using CDNAU or
ADV7UP in combination with the AJ56, AJ48, AJ27, and AJ23 primers,
respectively. For
c-/- x
pT
-/- thymi, a second nested PCR was
performed on the CDNAU/AJ48, CDNAU/AJ27, and CDNAU/AJ23 products
obtained above to produce more material. For these reactions, PCR were
performed with the AJ48, AJ27, or AJ23 primers in combination with the
CDNAU2-Bam primer. The conditions used for the PCR were 5 min at
94°C, followed by 35 cycles consisting of 30 s at 94°C,
30 s at 58°C, and 30 s at 72°C, and finally 10 min at
72°C.
Cloning and sequencing
The PCR products from E
-/- x
TCR
-/- mice were cloned in the
EcoRI and BamHI sites of pBlueScribe
KS- (Stratagene, La Jolla, CA). AC-positive
clones were sequenced using the Thermo Sequenase premixed cycle
sequencing kit (Amersham, Les Ullis, France) and analyzed on a Vistra
725 DNA Sequencer (Vistra Systems; Molecular Dynamics, Bondoulfe,
France). Rearrangements amplified from CD3
-deficient and
c
x pT
-double-deficient mice were ligated in the pSTBlue-1 vector
using the Perfectly Blunt Cloning kit (Novagen, Madison, WI). ADV2- or
ADV7-positive clones were sequenced by Genome Express S.A. (Grenoble,
France). ADV and AJ gene segments were identified by
comparison with the published sequences (22, 23).
| Results |
|---|
|
|
|---|
To analyze the TCRA gene rearrangement status at the
DNA level, we designed a PCR assay allowing amplification of
ADV genes rearranged to multiple successive AJ genes. This
multiplex PCR assay is performed by using ADV-specific
primers in combination with primers located downstream of different
AJ gene segments (AJ56, AJ48, AJ27, and AJ23), as shown in
Fig. 1
B. The PCR products were
then resolved on an agarose gel, transferred onto a nylon membrane, and
hybridized to a mix of AJ-specific probes (AJ56p, AJ48p,
AJ27p, AJ23p), as described in Materials and Methods. We
chose AJ segments located in the hot spot (HS) 1
(AJ56 and AJ48), and in the HS2 (AJ27
and AJ23). These HS could represent entry points for
recombination used early and late during development, respectively
(40, 49, 50, 51). Wild-type thymus DNA was amplified using
primers specific for the ADV2, ADV8, and
ADV10 family members in combination with the four AJ
primers. At least four rearrangements were easily detected in each
reaction (Fig. 2
). The same pattern is
observed when an ADV-specific primer is used to probe
amplified ADV-AJ rearrangements in place of the mix of
AJ-specific probes (data not shown). The use of probes
specific for AJ59, AJ51, AJ31, and
AJ27, individually, and longer resolution of PCR products on
agarose gels showed that the bands in the upper part of the gel are
true TCRA gene rearrangements, with the exception of the top
upper band in the AJ56 lane (Fig. 2
and data not shown).
AJ60, AJ59, AJ51, AJ29, and
AJ25 genes, described as pseudogenes, were never found,
whereas rearrangements using the AJ61 pseudogene were. No
rearrangements were found in RAG-2-/- mice, as
expected (Fig. 3
). In our assay, the DNA
input is 200 ng per PCR, or 800 ng for the set of four reactions. Cells
contain
6 pg DNA. Thus, with a set of four PCR, we analyze ADV-AJ
rearrangement in
1.3 x 105 cells. To
estimate the sensitivity of our assay, titration experiments were
performed. DNA prepared from TCR
+ SP wt
thymocytes was serially diluted in RAG-2-/-
thymocytes/DNA and a constant amount of these dilutions (200 ng per
PCR) were used as matrix. The PCR products were then resolved on
an agarose gel, transferred onto a nylon membrane, and probed with the
mix of four radiolabeled AJ probes, as described. ADV2-AJ
rearrangements could be detected when as little as 0.3%
TCR
+ SP thymocyte DNA is present in the
matrix (data not shown), which corresponds roughly to 400 cell
equivalents (0.3% of 1.3 x 105 cells).
|
|

and 
thymocytes, in
which pre-TCR expression is abolished because of genetic inactivation
of either CD3
or
c and pT
genes.
TCRA genes are rearranged in CD3
5/
5 mice
In CD3
5/
5 mice, T cell
differentiation is blocked at the DN3 stage. In a previous study, we
were unable to detect rearranged TCRA gene transcripts in
these mice (39), in accordance with previously published
results (15). However, rearranged TCRB gene
transcription is reduced in CD3
5/
5 mice
(15) and similarly, TCRA transcription could
have been reduced to undetectable levels. We therefore performed
multiplex PCR assay to determine whether the absence of rearranged
TCRA transcripts in CD3
5/
5
mice results from an absence of recombination at the DNA level.
DNA from CD3
5/
5,
RAG-2-/-, and wt thymi was amplified to
identify ADV10 family member rearrangement (Fig. 3
A). In CD3
5/
5, but not
RAG-2-/- mice, several bands were detected,
indicating the presence of TCRA rearrangements. The patterns
of utilization were not identical between two
CD3
5/
5 mice, but were quite diverse in
each case (detection of 8 and 10 bands in
CD3
5/
5 of 20 possible in wt mice).
AJ segments located in the HS2 are used, indicating that the
entire AJ region is accessible for recombination in DN
thymocytes. Finally, TCRA rearrangements are detected in
CD3e
5/
5 indifferently under either a BALB/c
or a C57BL/6 background.
The presence of TCR gene rearrangement in immature B cells
was previously described (52). To ensure that the
TCRA gene rearrangements observed in CD3
-deficient thymi
were produced in T and not B cells, DNA from sorted
CD3
5/
5 CD25+
thymocytes (purity >99%) was analyzed. Again we could detect various
TCRA gene rearrangements using ADV2 family members (Fig. 3
B). We detect
10 ADV2-AJ rearrangements in
1.3 x 105 CD25+ DN
CD3
5/
5 thymocytes. Our assay allows us
to determine the rearrangement status of 20 AJ segments of
60. One can then extrapolate that for the complete AJ
region, 3 times as many rearrangements are potentially present.
Similarly, because 10 rearrangements are detected for the
ADV2 family, it can be estimated that 22 times as many
rearrangements could be detected if one were to test all the
ADV families. From these extrapolations, it results that
10 x 22 x 3 = 660 rearrangements are potentially
present in 1.3 x 105
CD25+ DN CD3
5/
5
thymocytes, which indicates that
0.5% of these cells do have
rearranged TCRA genes.
TCRA rearrangements found in CD3
-deficient mice are diverse
To characterize the molecular nature of TCRA
rearrangements found in CD3
-deficient mice, TCRA
rearrangements using either the ADV2 or ADV7
family members, rearranged to AJ56, AJ48,
AJ27, or AJ23, were cloned and sequenced.
Sequencing showed that the ADV2 and ADV7 members
used in the CD3
5/
5 mouse analyzed are
diverse (Fig. 4
). Multiple junctions were
identified, which present nucleotide addition and/or deletion.
Insertions of >13 nucleotides at the ADV-AJ junction are
observed for three sequences. One of these is clearly DD2
gene segment. In three other junctions, a stretch of four or five
nucleotides matching DD1 or DD2 sequence can also
be identified. Rearrangement of a DD segment to
ADV and AJ segments was found in other studies
conducted in wt animals (unpublished results). Finally, analysis of the
sequences indicates that the thymocytes were not selected for in-frame
TCRA rearrangements, as expected because of absence of
surface expression.
|

5/
5 mice show that multiple
TCRA rearrangements can be completed as early as the
CD44-CD25+ stage of differentiation in
absence of signaling through pre-TCR, TCR, or clonotype-independent CD3
complex (CIC).
TCRA genes are rearranged in absence of the
c chain and pT
Overlapping signals derived from growth factors, cytokines, and Ag
receptors are essential for early T cell differentiation. Mice
deficient for the common cytokine receptor
-chain (
c) and pT
exhibit thymic hypoplasia (4 x 104
thymocytes) and a complete block of development at the
CD44+25+ stage. Despite
this low cellularity and early arrest, limited TCRB gene
rearrangements could nonetheless be found in total thymic DNA from
these mice (45). Thus, we next analyzed whether
ADV2-AJ recombination is also present.
Thymic DNA from
c x pT
double-deficient mice was amplified
using the AJ primers in combination with the ADV2
family-specific primer (Fig. 5
). A clear
signal was obtained with the two of three
c-/- x pT
-/-
mice shown. Although certain mice did not present TCRA
rearrangements involving ADV2 family members, a signal was
obtained using either ADV7- or ADV10-specific
oligonucleotides (Fig. 5
and data not shown). Only one sample of five
tested negative for both ADV2 and ADV10 (Fig. 5
and data not shown), a result that does not preclude the presence of
rearrangements involving other ADV families.
|
c-/- x
pT
-/- mice, a nested PCR protocol was used
to obtain sufficient material for cloning. Two samples showing
rearrangements with the different AJ primers were used. Various
TCRA gene rearrangements were sequenced (Fig. 6
|
c and the pre-TCR.
TCRA-rearranged transcripts are expressed in E
x TCR
double-deficient mice
To date, no TCRA transcripts have been found in
CD3
5/
5 mice (39). The
results presented in this study show nonetheless that TCRA
genes are rearranged in these mice, revealing an unsuspected level of
transcriptional regulation that could be controlled either by the
pre-TCR, or by CD3 alone, as CIC.
To investigate these possibilities, we analyzed TCRA gene
transcription in E
x TCR
double-deficient mice. In these
animals, thymocytes are blocked at the DN3 stage of development.
Absence of TCRB gene rearrangement and absence of TCR
chain expression preclude pre-TCR, TCR
, and TCR
expression
(47, 48), but CIC should not be affected. Rearranged
TCRA transcripts using ADV2, ADV3, and
ADV7 family members were analyzed by RT-PCR (Fig. 7
). Transcripts were detected for the
three ADV families studied in
E
-/- x TCR
-/-
and wt mice. As expected, no rearranged transcripts were detected in
CD3
5/
5 and
RAG2-/- mice. Thus, rearranged
TCRA genes can be transcribed in DN thymocytes in absence of
pre-TCR and TCR expression. Cloning and sequencing of ADV2-AC
amplification products revealed a high proportion of
ADV-DD-DJ rearrangements spliced onto the AC
segment (data not shown), as described in mice bearing the same
mutation in the DC segment and wt mice (53).
Nonetheless, bona fide ADV-AJ-AC transcripts (1535%) were
also identified, and sequencing showed utilization of different
AJ gene segments and ADV2 family members in the
two E
-/- x
TCR
-/- mice analyzed (data not shown). Thus,
rearranged TCRA genes can be transcribed in immature DN
thymocytes, in absence of pre-TCR and TCR expression. Together with the
absence of TCR
chain transcripts in
CD3
5/
5, this result strongly argues in
favor of a role for CIC complexes in the control of this
transcription.
|
| Discussion |
|---|
|
|
|---|
chain gene
recombination in DN thymocytes, in three different mouse models in
which early T cell differentiation is blocked at or before the
CD44-CD25+ stage of
maturation. The data presented in this study clearly show the presence
of a diverse set of TCRA rearrangements in all the mice
analyzed, demonstrating that TCR
,
,
, and
chains can be
produced during the early phases of T cell differentiation in the
thymus, in absence of any signaling via the CD3 complex either as part
of the pre-TCR, the TCR, or as CIC, or via
c-containing cytokine
receptors and the pre-TCR.
Until now, most of the available data indicated that TCRA
gene rearrangement only begins after pre-TCR signaling, at the DN/DP
transition. Our results now show that ADV-AJ recombination
is not so bluntly regulated, but is rather modulated during thymocyte
differentiation. This event already takes place in a fraction of
thymocytes during early DN stages, before being induced in most of the
cells while they mature to the DP stage. In CD3-deficient animals, we
estimated that
0.5% of immature thymocytes do have rearranged
TCRA genes. This low abundance and the randomness of
ADV-AJ recombination probably explain why different patterns
of ADV-AJ rearrangements are observed in different
CD3
5/
5 mice. However, this figure may be
higher in wt mice, as we cannot exclude that CD3, although not
necessary, participates in the regulation of gene accessibility when
expressed. In addition, it must be stressed out that this number is
only an estimate, since 1) all ADV gene families and all
AJ segments may not rearrange to the same extent (it is
known, for example, that ADV2 genes are used in
12% of
peripheral T cells), and 2) in our calculation, each PCR product
corresponds to only one rearrangement, whereas ADV-AJ
rearrangements are diverse (Fig. 4
).
In pT
-/- mice, 40% of the few DP cells that
can develop express an intracellular TCR
chain. The proportion of
-selected cells is nearly null in pT
-/-
x TCR
-/- mice, but raises to 95% in
pT
-/- x TCR
-/-
animals, indicating that pT
-/- thymocytes
that are not
selected differentiate under the influence of 
T
cells, and that early expression of a TCR
compensates for the
absence of pre-TCR and promotes DN/DP progression and
selection
(43). We previously found that rearranged TCRA
genes expressed in pT
-/- mice are diverse,
as in wt mice (40). However, in this study, we could not
formally rule out that the TCR
chain transcripts sequenced were
produced in those DP thymocytes that did differentiate under the
influence of 
+ thymocytes. The results
presented in this work demonstrate for the first time, at the DNA
level, the occurrence of diverse TCRA gene rearrangement in
a small subpopulation of immature pre-TCR-deficient thymocytes. In
addition, we show that TCRA gene rearrangement is
independent not only of pre-TCR expression, but also of expression of
either the CD3 complex, as CIC or associated with a 
TCR, or
c-containing cytokine receptors. Altogether, these findings provide
strong support to the hypothesis that TCRA rearrangements
produced in DN thymocytes are responsible for DP thymocyte development
in absence of pT
, at least partially in
pT
-/- animals, and probably totally in
pT
x TCR
double-deficient mice. Furthermore, the low
abundance of thymocytes having rearranged TCRA genes
probably explains why DP thymocyte number in
pT
-/- mice is only
2% of the wt level
(14). Because all of the T lymphocytes produced in
pT
-/- x TCR
-/-
animals use a TCR
chain generated in early thymocytes, these mice
constitute an ideal model to determine whether T lymphocytes using
these chains fully participate in all immune functions, or whether they
constitute a T lymphocyte subset with special homing or functional
properties. In a normal situation, the contribution of this
differentiation pathway to 
T lymphocyte development is probably
low compared with the pre-TCR pathway. Indeed, we must keep in mind
that, in wt mice, the majority of TCRA rearrangements take
place in DP cells and, even if our results show that the pre-TCR is not
required for TCRA gene rearrangements in DN thymocytes,
pre-TCR-induced proliferation vastly increases the number of cells that
will rearrange their TCRA genes.
TCRA gene rearrangement in early thymocytes does, however,
impact 
T lymphocyte development. In adult mice,

+ and 
+
thymocytes are generated from the same precursor population
(2). Numerous studies have tried to decipher the
mechanisms responsible for the dual fate of these precursors, and two
major models have emerged (see Ref. 3 for review). In the
separate lineage (or stochastic) model, lineage decision is imposed
first, and TCR genes rearrange later. If the TCR isotype
then expressed matches the lineage (e.g., 
TCR in 
thymocytes and pre-TCR in 
thymocytes), the cell survives and
differentiates. Otherwise, it dies. In the competitive rearrangement
(or instructive) model, the choice is dictated by the nature of the TCR
isotype expressed, either 
or pre-TCR, that
transduces different signals to the developing thymocytes. In both
models, only the 
TCR and the pre-TCR receptors are thought to be
instrumental for cell fate, differentiation, and/or survival. The
finding that TCRA genes can be rearranged and expressed in
the same DN2/DN3 population(s) as TCRD,
G, and B genes now offers the distinct
possibility that an 
TCR can also play a role in lineage
commitment, at least in two ways. First, it gives developing thymocytes
a new pathway to become an 
T lymphocyte, either by rescuing
committed precursors from death (stochastic), or by delivering
differentiation signals (instructive). Second, it reduces the
probability for a precursor to become a 
T lymphocyte. Indeed,
the unique genomic organization of the TCRAD locus is such
that any ADV-AJ rearrangement event will excise
TCRD genes from the chromosome. The progenitors will
therefore be allowed only one attempt to rearrange TCRD
genes on the remaining allele, and have only one chance of three to
succeed, compared with five of nine if both alleles are available.
Unlike 
thymocyte development, which includes a phase of intense
proliferation, 
T lymphocyte development is linear. Thus, in both
cases, and irrespective of the lineage commitment model considered, the
net result of TCRA gene rearrangement in early thymocytes
will be a depletion of 
T lymphocytes. However, it should be
noted that occurrence of ADV-AJ recombination in a T cell
progenitor does not per se preclude its development toward the 
lineage (44). Finally, in addition to their biological
significance, our findings do have another important consequence
regarding the study of 


lineage commitment: since
TCRA rearrangements can be detected as early as the DN2
stage of differentiation, they can no longer be considered a marker for



divergence operating after the pre-TCR.
TCRA rearrangements found in
pT
-/- mice are normal (40).
Recombination of TCRA genes also takes place in
TCR
-/- animals. In this study, in contrast
to previously published studies conducted in
CD3
5/
5 mice (15, 54), we
show that TCRA genes are also rearranged in absence of CD3
complex expression. Malissen and coworkers (15, 39, 54)
might have failed to detect TCRA gene rearrangement in these
animals because they did use an ADV8-specific
oligonucleotide and, in our hands, this family seems to be rearranged
at a very low level, if at all, in CD3-deficient mice (N. Pasqual,
S. J. C. Mancini, S. M. Candéias, and E.
Jouvin-Marche, unpublished results). Despite the presence of
TCRA rearrangements, TCR
chain transcripts were not
detected in CD3
5/
5 mice (Fig. 7
),
indicating that either the pre-TCR, the TCR, or CIC complexes are
required for the transcription of rearranged TCRA genes. In
contrast, TCRA transcripts were found in
E
-/- x TCR
-/-
mice, which lack conventional pre-TCR and TCR expression. An
alternative pre-TCR, composed of a TCR
chain associated with pT
and the CD3 complex, was recently described (55). However,
its expression would be expected to induce at least a low level of DP
thymocyte differentiation. As no DP population was observed among
E
-/- x TCR
-/-
thymocytes, TCR
/pT
complex expression was ruled out
(48). It seems therefore that no clonotypic TCR or pre-TCR
can be assembled in E
-/- x
TCR
-/- mice. One can argue that
ADV-AJ rearrangements in these mice result from
perturbations in the local control of accessibility, because of the
Neo cassette insertion near E
and blocking element

-1. Even though, any ADV-AJ rearrangement event will
excise the Neo cassette from the TCRAD locus, and
identical pattern of E
occupancy was found in
E
-/- x TCR
-/-
and RAG-1-/- thymocytes (56).
Therefore, transcriptional control of rearranged TCRA genes
in E
-/- x TCR
-/-
thymocytes is as in nonmanipulated animals. The presence of rearranged
TCR
chain transcripts in E
-/- x
TCR
-/- mice then suggests that the absence
of TCRA transcripts in CD3
5/
5
thymocytes results from CD3 deficiency. Thus, the CD3 complex is not
necessary for induction of TCRA gene rearrangement, but
rather seems to be involved in the transcriptional control of
rearranged TCRA genes, as previously suggested in the case
of TCRB genes (57).
It is clear in our study that TCRA rearrangements are both
pre-TCR and TCR independent. The CD3 complex is also dispensable, as
CIC. Furthermore, although it was shown that the pre-TCR provides
c-independent signal allowing the 
T cell differentiation in
c- mice (45), the induction of
TCRA gene rearrangement is independent of overlapping
c
and pre-TCR signals. Thus, none of the main molecules known to regulate
thymocyte development are required. What then are the signals
responsible for ADV-AJ recombination in early thymocytes?
One possibility is that they appear as a byproduct of TCRD
gene rearrangement, because of a faulty control of accessibility. The
other possibility is of course that TCRA genes are made
accessible to the recombination machinery only after a specific signal
is delivered to developing immature thymocytes. In the context of the
current model of enhancers as accessibility regulators,
ADV/AJ gene rearrangement in early thymocytes would suggest
that E
is already active in these cells and its activation is
independent of CD3- and
c-derived signals. However, E
is dispensable for ADV/AJ recombination. Its inactivation
only impairs, but does not abolish TCR
gene rearrangement
and expression (31, 32), showing that at least one other
yet unidentified element is able to promote ADV-AJ
recombination. Whether this element is responsible for
ADV-AJ rearrangement in immature thymocytes must await its
identification and elucidation of its regulation. In any case,
TCRA gene rearrangements are found as early as the
CD44+25+ stage of
development, at the time of TCRD gene rearrangement, in mice
in which T lymphocyte differentiation is blocked at an immature stage
because of genetic inactivation of different signaling pathways. It
remains to be formally demonstrated whether the same phenomenon also
takes place during normal thymocyte development in wt mice.
| Acknowledgments |
|---|
| Footnotes |
|---|
2 Address correspondence and reprint requests to Dr. Serge M. Candéias, Commissariat à lEnergie Atomique-G, Département de Biologic Moléculaire et Structurale/Laboratoire dImmunochimie, Institut National de la Santé et de la Recherche Médicale Unité 548, 17 rue des martyrs, 38054 Grenoble, Cedex, France. E-mail address: immuno{at}dsvsud.cea.fr ![]()
3 Abbreviations used in this paper: DN, double negative; CIC, clonotype-independent CD3 complex; DP, double positive; HS, hot spot; RAG, recombination-activating gene; SP, single positive; wt, wild type. ![]()
Received for publication June 29, 2001. Accepted for publication August 15, 2001.
| References |
|---|
|
|
|---|



lineage commitment in the thymus of normal and genetically manipulated mice. Adv. Immunol. 71:1.[Medline]
,
, and
rearrangements during adult thymic development: T cell receptor rearrangements are present in CD44+CD25+ pro-T thymocytes. Proc. Natl. Acad. Sci. USA 95:12522.
chain and a 33 kd glycoprotein. Cell 75:283.[Medline]
subunit. J. Exp. Med. 182:1585.
is physically associated but not functionally required. J. Exp. Med. 186:1461.
gene in development of 
but not 
T cells. Nature 375:795.[Medline]
gene. EMBO J. 14:4641.[Medline]
and CD3
for development of 
and 
T lymphocytes. J. Exp. Med. 188:1375.
in T cell development. Proc. Natl. Acad. Sci. USA 95:14909.
chain is essential for development of both the TCR
and TCR
lineages. EMBO J. 17:1871.[Medline]

versus 
T lineage commitment. Immunity 9:649.[Medline]
family. EMBO J. 9:2141.[Medline]
/C
) region: organization, sequence, and evolution of 97.6 kb of DNA. Genomics 19:478.[Medline]
/
locus. Immunol. Rev. 165:131.[Medline]
locus. EMBO J. 8:729.[Medline]
locus. Science 247:1225.
and TCR
gene enhancers confer tissue- and stage- specificity on V(D)J recombination events. EMBO J. 12:4335.[Medline]
/
gene rearrangement by T cell receptor
and
enhancers. J. Exp. Med. 179:1913.
/
locus impairs T-cell development and reveals the presence of the nearby antiapoptosis gene Dad1. Mol. Cell. Biol. 17:2151.[Abstract]
enhancer in 
and 
T cells. Immunity 7:505.[Medline]
locus accessibility and expression by the TCR
enhancer. Immunity 10:503.[Medline]
and
gene segments within the human T cell receptor
/
locus. Proc. Natl. Acad. Sci. USA 94:5219.
gene rearrangement and T early
(TEA) expression in immature 
lineage thymocytes: implications for 
/
lineage commitment. Immunity 4:37.[Medline]
locus allelic exclusion and initiation of TCR-
locus rearrangement in immature thymocytes by signaling through the CD3 complex. Eur. J. Immunol. 25:1257.[Medline]
or CD3


. J. Immunol. 162:88.
chain is independent of their position and of CD3 expression. Eur. J. Immunol. 28:3878.[Medline]
-chain repertoire in pT
-deficient mice is diverse and developmentally regulated: implications for pre-TCR functions and TCRA gene rearrangement. J. Immunol. 163:6053.
lineage-committed thymocytes can be rescued by the 
T cell receptor (TCR) in the absence of TCR
chain. Eur. J. Immunol. 27:2948.[Medline]
selection events in 
cell development. Immunity 7:83.[Medline]
gene rearrangement and transcription in adult thymic gamma
cells. Eur. J. Immunol. 27:389.[Medline]
chain and the pre-T cell receptor provide independent but critically overlapping signals in early
/
T cell development. J. Exp. Med. 189:563.
-chain gene rearrangement: coincident regulation of cell cycle and clonality during development in vivo. Genes Dev. 10:948.
locus: differential effects on DNA cleavage and joining. Genes Dev. 12:2305.
enhancer-deleted mice: implications for 
T cell lineage commitment and differentiation. J. Immunol. 165:1364.
locus. Eur. J. Immunol. 24:107.[Medline]
gene rearrangement in fetal and neonatal thymocytes. Eur. J. Immunol. 26:1892.[Medline]
and
chains of the mouse TCR. Eur. J. Immunol. 28:818.[Medline]
sequences to the constant region of the
locus. Proc. Natl. Acad. Sci. USA 95:5694.
gene regulatory sequences prevent the function of a novel TCR
/pT
pre-T cell receptor. Immunity 8:713.[Medline]
enhancer activation occurs via a conformational change of a pre-assembled nucleo-protein complex. EMBO J. 19:2034.[Medline]
VDJ genes in early thymic development. J. Exp. Med. 188:1669.This article has been cited by other articles:
![]() |
D. W. Hendricks and P. J. Fink Uneven Colonization of the Lymphoid Periphery by T Cells That Undergo Early TCR{alpha} Rearrangements J. Immunol., April 1, 2009; 182(7): 4267 - 4274. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Kalmanovich and R. Mehr Models for Antigen Receptor Gene Rearrangement. III. Heavy and Light Chain Allelic Exclusion J. Immunol., January 1, 2003; 170(1): 182 - 193. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Pasqual, M. Gallagher, C. Aude-Garcia, M. Loiodice, F. Thuderoz, J. Demongeot, R. Ceredig, P. N. Marche, and E. Jouvin-Marche Quantitative and Qualitative Changes in V-J {alpha} Rearrangements During Mouse Thymocytes Differentiation: Implication For a Limited T Cell Receptor {alpha} Chain Repertoire J. Exp. Med., November 4, 2002; 196(9): 1163 - 1174. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |